■ 刊行論文
|
原著
|
|
1.
|
Tokuyasu D, Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S†, Kubota T, Samukawa M, Sugimoto T, Ishizuchi K, Oyama M, Yasuda M, Akamine H, Onishi Y, Suzuki Y, Kawaguchi N, Minami N, Kimura T, Takahashi MP, Murai H, Utsugisawa K：
. Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Ann Clin Transl Neurol. 2024 Apr 4.
Ann Clin Transl Neurol.
X
(doi: 10.1002/acn3.52051.)
：
, 2024
|
|
2.
|
Konno S†＊, Uchi T†, Kihara H†, Sugimoto H†.：
Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool.
Journal of the Neurological Sciences
460
(15)
：
, 2024
|
|
3.
|
Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S†. Kubota T, Samukawa M, Ishizuchi K, Tokuyasu D, Handa H, Yasuda M, Kawaguchi N, Kimura T, Suzuki Y, Sugimoto T, Minami N, Takahashi MP, Murai H, Utsugisawa K.：
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.
Neurol Clin Pract.
14
(3)
：
, 2024
|
|
